logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11771759 B1

PDFFull Text
Date of Patent:
Oct. 03, 2023

Filed:

Jan. 24, 2018

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use

Applicant:

Fudan University, Shanghai, CN;

Inventors:

Bin Wang, Shanghai, CN;

Weidong Zhao, Shanghai, CN;

Gan Zhao, Shanghai, CN;

Yiwei Zhong, Shanghai, CN;

Assignee:

Fudan University, Shanghai, CN;

Attorney:

K&L Gates LLP

Primary Examiner:

Rachel B Gill

Int. Cl.
CPC ...
A61K 39/29 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/09 (2006.01); A61K 39/39 (2006.01); C12N 7/00 (2006.01); C07K 14/52 (2006.01); C07K 14/535 (2006.01); C07K 14/565 (2006.01);
U.S. Cl.
CPC ...
A61K 39/29 (2013.01); A61K 39/001157 (2018.08); A61K 39/001186 (2018.08); A61K 39/001193 (2018.08); A61K 39/092 (2013.01); A61K 39/39 (2013.01); A61P 35/00 (2018.01); C07K 14/52 (2013.01); C07K 14/535 (2013.01); C07K 14/565 (2013.01); C12N 7/00 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/804 (2018.08); A61K 2039/812 (2018.08); A61K 2039/868 (2018.08); A61K 2039/884 (2018.08); A61K 2039/892 (2018.08); C12N 2730/10011 (2013.01); C12N 2730/10034 (2013.01); C12N 2730/10134 (2013.01);
Abstract

An immune enhancer comprising at least an interferon and a granulocyte-macrophage colony-stimulating factor, and an immunotherapeutic phar-maceutical composition comprising at least an antigen and the above-mentioned immune enhancers is disclosed. A preparation method of the immunotherapeutic pharmaceutical composition, the use of the immune enhancer and the immunotherapeutic pharmaceutical composition are also disclosed. The immune enhancer can be applied to disease and tumor treatments caused by viruses, bacteria, and other microorganisms.

Find Patent Forward Citations

Wang, Bin. (2023). Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use (U.S. Patent No. 11771759). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11771759

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…